Literature DB >> 20386049

The interface of primary and oncology specialty care: from symptoms to diagnosis.

Larissa Nekhlyudov1, Steven Latosinsky.   

Abstract

Symptomatic individuals presenting to their primary care providers may need further evaluation and/or testing to determine whether a cancer is present. A number of issues arise in determining who needs further testing, what tests are needed, which specialists need to be involved, and how the testing can be organized and supported within a specific health-care system within a timely, coordinated, and cost-efficient manner. This article explores the challenges in the interface of primary care providers and specialists, includes evidence from prior research, and proposes research opportunities to understand and improve this phase of care.

Entities:  

Mesh:

Year:  2010        PMID: 20386049      PMCID: PMC3482946          DOI: 10.1093/jncimonographs/lgq001

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  80 in total

1.  National benchmarking between the Nordic countries on the quality of care.

Authors:  Jan Mainz; Morten Hjulsager; Mette Thorup Eriksen Og; Jytte Burgaard
Journal:  J Surg Oncol       Date:  2009-06-15       Impact factor: 3.454

2.  The future of primary care: lessons from the U.K.

Authors:  Martin Roland
Journal:  N Engl J Med       Date:  2008-11-13       Impact factor: 91.245

3.  Physicians' experiences and beliefs regarding informal consultation.

Authors:  N L Keating; A M Zaslavsky; J Z Ayanian
Journal:  JAMA       Date:  1998-09-09       Impact factor: 56.272

4.  General practictioners' management of cancer in England: secondary analysis of data from the National Survey of NHS Patients-Cancer.

Authors:  V L Allgar; R D Neal
Journal:  Eur J Cancer Care (Engl)       Date:  2005-12       Impact factor: 2.520

5.  Access to care and satisfaction in colorectal cancer patients.

Authors:  Geoffrey A Porter; Karen M Inglis; Lori A Wood; Paul J Veugelers
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

6.  Reasons for delay in breast cancer diagnosis.

Authors:  L S Caplan; K J Helzlsouer; S Shapiro; M N Wesley; B K Edwards
Journal:  Prev Med       Date:  1996 Mar-Apr       Impact factor: 4.018

7.  Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy.

Authors:  G A J Fransen; M J R Janssen; J W M Muris; R J F Laheij; J B M J Jansen
Journal:  Aliment Pharmacol Ther       Date:  2004-11-15       Impact factor: 8.171

Review 8.  Management of palpable breast lumps. Consensus guideline for family physicians.

Authors:  R Heisey; L Mahoney; B Watson
Journal:  Can Fam Physician       Date:  1999-08       Impact factor: 3.275

9.  The '2-week wait' rule for referrals for suspected urological cancers--urgent need for refinement of criteria.

Authors:  Amr M Hawary; Hazel E Warburton; Richard J Brough; Gerald N Collins; Stephen C Brown; Patrick H O'Reilly; Adebanji Ab Adeyoju
Journal:  Ann R Coll Surg Engl       Date:  2008-09       Impact factor: 1.891

Review 10.  Evaluation of diagnostic assessment units in oncology: a systematic review.

Authors:  Anna Gagliardi; Eva Grunfeld; William K Evans
Journal:  J Clin Oncol       Date:  2004-03-15       Impact factor: 44.544

View more
  27 in total

Review 1.  Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care.

Authors:  Stephen Hunt Taplin; Anne Brown Rodgers
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 2.  Interfaces across the cancer continuum offer opportunities to improve the process of care.

Authors:  Stephen H Taplin; Steve Clauser; Anne B Rodgers; Erica Breslau; Daniel Rayson
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  Referrals for suspected hematologic malignancy: a survey of primary care physicians.

Authors:  Gregory A Abel; Christopher R Friese; Bridget A Neville; Katherine M Wilson; B Taylor Hastings; Craig C Earle; Nancy L Keating; Lisa C Richardson
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

4.  Introduction: Understanding and influencing multilevel factors across the cancer care continuum.

Authors:  Stephen H Taplin; Rebecca Anhang Price; Heather M Edwards; Mary K Foster; Erica S Breslau; Veronica Chollette; Irene Prabhu Das; Steven B Clauser; Mary L Fennell; Jane Zapka
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

5.  Outside the box: will information technology be a viable intervention to improve the quality of cancer care?

Authors:  Bradford W Hesse; Christopher Hanna; Holly A Massett; Nicola K Hesse
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 6.  Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care.

Authors:  Jane Zapka; Stephen H Taplin; Rebecca Anhang Price; Caroline Cranos; Robin Yabroff
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 7.  Bridging the gap between care: is speed dating the answer?

Authors:  Samantha Harrison; Larissa Nekhlyudov; Debbie Bell; Sarah Bowdage; Brian D Nicholson
Journal:  Br J Gen Pract       Date:  2020-01-30       Impact factor: 5.386

8.  Cognitive errors and logistical breakdowns contributing to missed and delayed diagnoses of breast and colorectal cancers: a process analysis of closed malpractice claims.

Authors:  Eric G Poon; Allen Kachalia; Ann Louise Puopolo; Tejal K Gandhi; David M Studdert
Journal:  J Gen Intern Med       Date:  2012-05-19       Impact factor: 5.128

9.  Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists.

Authors:  Winson Y Cheung; Noreen Aziz; Anne-Michelle Noone; Julia H Rowland; Arnold L Potosky; John Z Ayanian; Katherine S Virgo; Patricia A Ganz; Michael Stefanek; Craig C Earle
Journal:  J Cancer Surviv       Date:  2013-03-24       Impact factor: 4.442

10.  Electronic Trigger-Based Intervention to Reduce Delays in Diagnostic Evaluation for Cancer: A Cluster Randomized Controlled Trial.

Authors:  Daniel R Murphy; Louis Wu; Eric J Thomas; Samuel N Forjuoh; Ashley N D Meyer; Hardeep Singh
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.